Figure 10A from STRING showed 10 co-expression genes of DTYMK and a PPI network. As shown in Figure 10B, results from the GeneMANIA suggested that DTYMK and its co-expression genes were involved in pyrimidine–containing compound biosynthetic process and pyrimidine nucleotide biosynthetic/metabolic process. Furthermore, we studied the genetic alteration characteristics of DTYMK across different tumors of the TCGA cohorts with the cBioPortal web. The result in Figure 10C showed that the most alteration frequency of DTYMK appeared in sarcoma patients with “deep deletion” as the main type. The gene discussed is DTYMK; the disease is sarcoma.